Objective responses to first-line neoadjuvant carboplatin–paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial
Robert D. Morgan, Iain A. McNeish, Adrian D. Cook, Elizabeth C. James, Rosemary Lord, Graham Dark, Rosalind M. Glasspool, Jonathan Krell, Christine Parkinson, Christopher J. Poole, Marcia Hall, Dolores Gallardo-Rincón, Michelle Lockley, Sharadah Essapen, Jeff Summers, Anjana Anand, Abel Zachariah, Sarah Williams, Rachel Jones, Kate ScatchardAxel Walther, Jae Weon Kim, Sudha Sundar, Gordon C. Jayson, Jonathan A. Ledermann, Andrew R. Clamp*
Research output: Contribution to journal › Article › peer-review
8Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Objective responses to first-line neoadjuvant carboplatin–paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial'. Together they form a unique fingerprint.